HOME >> BIOLOGY >> NEWS
UCSF begins distributing the first of its two embryonic stem cell lines

cell biology research," says Regis B. Kelly, PhD, UCSF executive vice chancellor, office of research. "The best way to determine the therapeutic potential of embryonic stem cells is to foster research efforts in many laboratories, and the role of University labs in this effort is critical, as there is less need to focus on financial implications."

"We are very pleased to be able to share these cells with other academic researchers. The effort that has gone in to getting these cells ready for distribution has been worthwhile. Studying the basic biology of embryonic stem cells is a key step in exploring their therapeutic potential," says Meri Firpo, PhD, UCSF assistant research geneticist in the Department of Obstetrics, Gynecology and Reproductive Sciences.

Firpo led the team that derived the two cell lines in the UCSF laboratory of Roger Pedersen, PhD, at that time UCSF professor and research director, reproductive genetics unit, Department of Obstetrics, Gynecology and Reproductive Sciences, and now at the University of Cambridge, in England.

Firpo and her colleagues derived the two lines of embryonic stem cells in the winter and spring of 2001. The cells were obtained from three to five day old embryos that had been left over following fertility treatments and had been donated for research. The cells were then developed into cell "lines," large quantities of genetically identical cells created by replication initiated with a single cell in the laboratory dish.

Last fall and winter, following the establishment of the NIH Human Embryonic Stem Cell Registry, the University of California Office of the President and UCSF negotiated mutually agreeable terms with several institutions for sharing the cells with academic researchers. The negotiations took place with Geron, which funded the research and holds the exclusive commercial license to the two stem cell lines; WiCell Research Institute, a nonprofit subsidiary of Wisconsin Alumni Res
'"/>

Contact: Jennifer OBrien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Sep-2002


Page: 1 2 3 4 5

Related biology news :

1. New hydrothermal vents discovered as South Pacific Odyssey research begins
2. DCI donor services begins distribution of tissue implants
3. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
4. Work begins on powering a sustainable future for the UK
5. As autumn approaches, this chickadees brain begins to expand
6. New study begins to unravel fate of toxic pollutants harbored in Arctic waters
7. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
8. Nabi Biopharmaceuticals begins human testing of novel vaccine to fight nicotine addiction
9. The pathway to anxiety begins early in life
10. DOE begins international effort to sequence tree genome
11. Montana State University begins major trout and salmonid book collection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... 1, 2016 The report "Biometric ... Future Technology (Iris Recognition System), Vehicle Type (Passenger ... Forecast to 2021", published by MarketsandMarkets, the market ... 2016, and is projected to grow to USD ... 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... -- higi SH llc (higi) announced today the launch ... industry thought-leaders and celebrity influencers looking to encourage, ... steps to live healthier, more active lives. ... built the largest self-screening health station network in ... have conducted over 185 million biometric screenings.  The ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... and SAN DIEGO , Dec. ... the appointment of Santosh Kesari , MD, PhD, ... will leverage his experience in neurology and clinical trials ... stem cell for treatment of stroke. The AmnioStem product is ... which has previously shown therapeutic activity in animal models ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International has ... million from the National Institutes of Health,s National ... Division of AIDS (NIAID-DAIDS) to support the manufacturing ... pre-exposure (PreP) agents. Under the seven-year contract, SRI ... development services for candidate HIV-prevention products that emerge ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company focused on discovery and development of precision treatments for neurodegenerative diseases, ... for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like forms ...
(Date:12/5/2016)... Dec. 5, 2016 Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced that ... treatment of Alzheimer,s disease will be presented at the ... Friday, December 9, 2016 in San Diego ... of both simple and complex measures of activities of ...
Breaking Biology Technology:
Cached News: